Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

Leukemia

Volumn 24, Issue 1, 2010, Pages 58-65

  Shaw, B E ^a,b   Mayor, N P ^a,c   Russell, N H ^d   Apperley, J F ^e   Clark, R E ^f   Cornish, J ^g   Darbyshire, P ^h   Ethell, M E ^b   Goldman, J M ^a,i   Little, A M ^j   MacKinnon, S ^c   Marks, D I ^g   Pagliuca, A ^k   Thomson, K ^c   Marsh, S G E ^a,c   Madrigal, J A ^a,c  

^a ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^h BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

^j GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^k KING S COLLEGE HOSPITAL   (United Kingdom)

more..

Author keywords

Disease stage; HLA DPB1; Leukaemia; Volunteer unrelated donor

Indexed keywords

ALEMTUZUMAB; CYCLOSPORIN A; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; METHOTREXATE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER RELAPSE; CANCER STAGING; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DONOR; FEMALE; GENE LOCUS; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SCHOOL CHILD; T CELL DEPLETION; TREATMENT OUTCOME;

EID: 74249117356     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.239     Document Type: Article

References (32)

1. Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004; 104: 1923-1930.
2. Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576-4583.
3. Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002; 99: 4200-4206.
4. Morishima Y, Yabe T, Matsuo K, Kashiwase K, Inoko H, Saji H et al. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor. Biol Blood Marrow Transplant 2007; 13: 315-328.
5. Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D et al. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant 2001; 7: 620-630.
6. Petersdorf EW, Anasetti C, Martin PJ, Gooley T, Radich J, Malkki M et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 2004; 104: 2976-2980.
7. Shaw BE, Russell NH, Devereux S, Das-Gupta E, Mackinnon S, Madrigal JA et al. The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors. Haematologica 2005; 90: 1562-1569.
8. Kawase T, Morishima Y, Matsuo K, Kashiwase K, Inoko H, Saji H et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood 2007; 110: 2235-2241.
9. Shaw BE, Gooley TA, Malkki M, Madrigal JA, Begovich AB, Horowitz MM et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood 2007; 110: 4560-4566.
10. Shaw BE, Marsh SG, Mayor NP, Russell NH, Madrigal JA. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 2006; 107: 1220-1226.
11. Loiseau P, Esperou H, Busson M, Sghiri R, Tamouza R, Hilarius M et al. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation. Bone Marrow Transplant 2002; 30: 497-502.
12. Fleischhauer K, Zino E, Mazzi B, Sironi E, Servida P, Zappone E et al. Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901. Blood 2001; 98: 1122-1126.
13. Gaschet J, Gallot G, Ibisch C, Lim A, Even J, Vivien R et al. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets. Bone Marrow Transplant 1998; 22: 385-392.
14. Ibisch C, Gallot G, Vivien R, Diez E, Jotereau F, Garand R et al. Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation. Bone Marrow Transplant 1999; 23: 1153-1159.
15. Rutten CE, van Luxemburg-Heijs SA, Griffioen M, Marijt EW, Jedema I, Heemskerk MH et al. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia. Leukemia 2008; 22: 1387-1394.
16. Valdes AM, McWeeney SK, Meyer D, Nelson MP, Thomson G. Locus and population specific evolution in HLA class II genes. Ann Hum Genet 1999; 63 (Part 1): 27-43.
17. Hollenbach JA, Thomson G, Cao K, Fernandez-Vina M, Erlich HA, Bugawan TL et al. HLA diversity, differentiation, and haplotype evolution in Mesoamerican natives. Hum Immunol 2001; 62: 378-390.
18. Tiercy JM, Nicoloso G, Passweg J, Schanz U, Seger R, Chalandon Y et al. The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable. Bone Marrow Transplant 2007; 40: 515-522.
19. Hurley CK, Baxter-Lowe LA, Begovich AB, Fernandez-Vina M, Noreen H, Schmeckpeper B et al. The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairs. Bone Marrow Transplant 2000; 25: 385-393.
20. Petersdorf EW, Gooley T, Malkki M, Anasetti C, Martin P, Woolfrey A et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol 2001; 112: 988-994.
21. Rodriguez T, Mendez R, Del Campo A, Aptsiauri N, Martin J, Orozco G et al. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines. Immunogenetics 2007; 59: 123-133.
22. Shaw S, Johnson AH, Shearer GM. Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses. J Exp Med 1980; 152: 565-580.
23. Laux G, Mansmann U, Deufel A, Opelz G, Mytilineos J. A new epitope-based HLA-DPB matching approach for cadaver kidney retransplants. Transplantation 2003; 75: 1527-1532.
24. de Koster HS, Anderson DC, Termijtelen A. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J Exp Med 1989; 169: 1191-1196.
25. Essaket S, Fabron J, de Preval C, Thomsen M. Corecognition of HLA-A1 and HLA-DPw3 by a human CD4+ alloreactive T lymphocyte clone. J Exp Med 1990; 172: 387-390.
26. Zino E, Frumento G, Marktel S, Sormani MP, Ficara F, Di Terlizzi S et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 2004; 103: 1417-1424.
27. Shaw BE, Marsh SGE, Mayor NP, Madrigal JA. Matching status at amino acid positions 57 and 65 of the HLA-DPB1 beta chain determines outcome in recipients of Unrelated Donor Haematopoietic Stem Cell Transplants (abstract). Blood 2004; 104: 827.
28. Zino E, Vago L, Di Terlizzi S, Mazzi B, Zito L, Sironi E et al. Frequency and targeted detection of HLA-DPB1T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 1031-1040.
29. Crocchiolo R, Zino E, Vago L, Oneto R, Bruno B, Pollichieni S et al. Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood 2009; 114: 1437-1444.
30. Kawase T, Matsuo K, Kashiwase K, Inoko H, Saji H, Ogawa S et al. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. Blood 2009; 113: 2851-2858.
31. Ludajic K, Balavarca Y, Bickeboller H, Pohlreich D, Kouba M, Dobrovolna M et al. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT. Br J Haematol 2008; 142: 436-443.
32. Shaw BE, Potter MN, Mayor NP, Pay AL, Smith C, Goldman JM et al. The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 31: 1001-1008.